Quarterly report pursuant to Section 13 or 15(d)

General (Details)

v3.22.1
General (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Oct. 28, 2019
Mar. 31, 2022
General (Details) [Line Items]    
Recapitalization transaction, percentage 100.00%  
Total consideration from merger (in Dollars)   $ 60,100
BiomX Israel [Member]    
General (Details) [Line Items]    
Shareholders total shares (in Shares) 15,069,058  
Total shares issued and outstanding, percentage 65.00%